519 related articles for article (PubMed ID: 9536388)
21. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis.
Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF
Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904
[TBL] [Abstract][Full Text] [Related]
22. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
23. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
Seibold JR; Harris JN
J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
[TBL] [Abstract][Full Text] [Related]
24. [Myocardial microvascularization in scleroderma].
Kahan A; Devaux JY; Weber S; Nitenberg A; Amor B; Menkes CJ; Guerin F; Degeorges M
Arch Mal Coeur Vaiss; 1988 Apr; 81(4):495-500. PubMed ID: 3136710
[TBL] [Abstract][Full Text] [Related]
25. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.
Pancera P; Sansone S; Presciuttini B; Montagna L; Cerù S; Lunardi C; Lechi A
Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis.
Shuck JW; Oetgen WJ; Tesar JT
Am J Med; 1985 Feb; 78(2):221-7. PubMed ID: 3970048
[TBL] [Abstract][Full Text] [Related]
27. The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon.
Engelhart M; Seibold JR
Angiology; 1990 Sep; 41(9 Pt 1):715-23. PubMed ID: 2221472
[TBL] [Abstract][Full Text] [Related]
28. Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon.
Matsuda J; Tsukamoto M; Gohchi K; Saitoh N; Miyajima Y; Kazama M
Acta Haematol; 1992; 88(4):189-93. PubMed ID: 1337960
[TBL] [Abstract][Full Text] [Related]
29. Raynaud's phenomenon and systemic sclerosis.
Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
[TBL] [Abstract][Full Text] [Related]
30. Raynaud's phenomenon.
Wigley FM; Flavahan NA
Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
[TBL] [Abstract][Full Text] [Related]
31. Raynaud's phenomenon of the lung.
Fahey PJ; Utell MJ; Condemi JJ; Green R; Hyde RW
Am J Med; 1984 Feb; 76(2):263-9. PubMed ID: 6695950
[TBL] [Abstract][Full Text] [Related]
32. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.
Alexander EL; Firestein GS; Weiss JL; Heuser RR; Leitl G; Wagner HN; Brinker JA; Ciuffo AA; Becker LC
Ann Intern Med; 1986 Nov; 105(5):661-8. PubMed ID: 3767147
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiological classification of Raynaud's phenomenon.
Nilsen KH
Br J Dermatol; 1980 Jan; 102(1):1-5. PubMed ID: 7378276
[TBL] [Abstract][Full Text] [Related]
34. A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
Kahan A; Amor B; Menkes CJ
Ann Rheum Dis; 1985 Jan; 44(1):30-3. PubMed ID: 3882061
[TBL] [Abstract][Full Text] [Related]
35. [Raynaud's phenomena: diagnostic and treatment study].
Priollet P
Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
[TBL] [Abstract][Full Text] [Related]
36. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
[TBL] [Abstract][Full Text] [Related]
37. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
[TBL] [Abstract][Full Text] [Related]
38. Postocclusive reactive hyperemia in hand-arm vibration syndrome.
Stoyneva Z
Int J Occup Med Environ Health; 2016; 29(4):659-66. PubMed ID: 27443761
[TBL] [Abstract][Full Text] [Related]
39. Myocardial perfusion in peripheral Raynaud's phenomenon. Evaluation using stress cardiovascular magnetic resonance.
Mavrogeni S; Bratis K; Koutsogeorgopoulou L; Karabela G; Savropoulos E; Katsifis G; Raftakis J; Markousis-Mavrogenis G; Kolovou G
Int J Cardiol; 2017 Feb; 228():444-448. PubMed ID: 27870974
[TBL] [Abstract][Full Text] [Related]
40. Systemic lupus erythematosus and Raynaud's phenomenon.
Heimovski FE; Simioni JA; Skare TL
An Bras Dermatol; 2015; 90(6):837-40. PubMed ID: 26734864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
